dexmedetomidine has been researched along with Spinal Cord Injuries in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WC; He, HF; Li, W; Lin, YL; Liu, WF; Liu, YB; Xu, CJ | 1 |
| Chen, T; Kang, G; Li, M; Luo, X; Qiu, X; Yan, L; Zhao, K | 1 |
| Beattie, MS; Bresnahan, JC; Chang, YW; Du, Q; Gao, J; Lin, A; Maze, M; Niu, X; Pan, JZ; Sun, W; Sun, Y; Sun, Z; Wang, G; Xiao, Z | 1 |
| Feng, WZ; He, FY; Shao, HY; Xu, W; Zhang, YR; Zhong, J | 1 |
| He, H; He, X; Lin, W; Wang, S; Zhou, Y; Zhuang, J | 1 |
| Jiao, ZH; Wang, L; Wang, WG; Xu, ZW; Xue, B | 1 |
| Celik, F; Evliyaoğlu, O; Fırat, U; Göçmez, C; Guzel, A; Kamaşak, K; Tokgoz, O; Tufek, A | 1 |
| Ji, D; Li, H; Li, SS; Xiong, YC; Xu, H; Yang, JL; Zhang, WS; Zhang, YQ; Zhou, YL | 1 |
| Lee, KH | 1 |
| Bell, MT; Cleveland, JC; Foley, LS; Freeman, KA; Fullerton, DA; Herson, PS; Mares, JM; Meng, X; Puskas, F; Reece, TB; Weyant, MJ | 1 |
| Hai-Chen, C; Ji-Shun, N; Shou-Shi, W; Ting-Ting, S | 1 |
| Feng, J; Gu, X; Hou, B; Lei, Y; Liu, Y; Ma, Z; Rong, H; Sun, R; Sun, Y; Wu, H; Zhang, W; Zhang, Z; Zhao, Z | 1 |
| Altunbaş, K; Aslan, A; Baş, O; Buyukokuroglu, ME; Cemek, M; Cosar, M; Ela, Y; Eser, O; Fidan, H | 1 |
| Acikgoz, S; Bektas, S; Can, M; Gul, S; Hanci, V | 1 |
| Acikgoz, B; Acikgoz, S; Ankarali, H; Bahadir, B; Bektas, S; Gul, S; Hanci, V; Kalayci, M | 1 |
| Fitzgerald, M; Walker, SM | 1 |
16 other study(ies) available for dexmedetomidine and Spinal Cord Injuries
| Article | Year |
|---|---|
Dexmedetomidine alleviates traumatic spinal cord injury in rats via inhibiting apoptosis induced by endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Dexmedetomidine; Disease Models, Animal; Endoplasmic Reticulum Stress; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 2022 |
Dexmedetomidine promotes spinal cord injury repairing via activating Nrf2/HO-1 signaling pathway.
Topics: Animals; Dexmedetomidine; Heme Oxygenase (Decyclizing); NF-E2-Related Factor 2; Rats; Signal Transduction; Spinal Cord; Spinal Cord Injuries | 2020 |
Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cells, Cultured; Dexmedetomidine; Disease Models, Animal; Female; Inflammation; Microglia; Rats; Rats, Long-Evans; Receptors, Adrenergic, alpha-2; Signal Transduction; Spinal Cord; Spinal Cord Injuries | 2019 |
Effects of propofol and dexmedetomidine anesthesia on Th1/Th2 of rat spinal cord injury.
Topics: Anesthesia; Animals; Cytokines; Dexmedetomidine; Propofol; Rats; Spinal Cord Injuries; Th1-Th2 Balance; Time Factors | 2017 |
Dexmedetomidine Mitigates Microglia-Mediated Neuroinflammation through Upregulation of Programmed Cell Death Protein 1 in a Rat Spinal Cord Injury Model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Inflammatory Agents; Dexmedetomidine; Inflammation; Male; Microglia; Programmed Cell Death 1 Receptor; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Up-Regulation | 2018 |
Locomotor activity of rats with SCI is improved by dexmedetomidine by targeting the expression of inflammatory factors.
Topics: Animals; Dexmedetomidine; Gene Expression Regulation; Inflammation Mediators; Interleukin-1beta; Locomotion; Male; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2018 |
The comparison of neuroprotective effects of intrathecal dexmedetomidine and metilprednisolone in spinal cord injury.
Topics: Animals; Dexmedetomidine; Disease Models, Animal; Female; Hemorrhage; Histocytochemistry; Injections, Spinal; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Statistics, Nonparametric | 2013 |
Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI.
Topics: Analgesics, Non-Narcotic; Animals; Cells, Cultured; Chronic Disease; Constriction, Pathologic; Dexmedetomidine; Hyperalgesia; Interleukin-18; Male; Microglia; Pain Threshold; Physical Stimulation; Posterior Horn Cells; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Spinal Cord Injuries; Touch | 2014 |
Dexmedetomidine for chronic spinal cord injured patient.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Dexmedetomidine; Female; Humans; Male; Spinal Cord Injuries | 2014 |
Alpha-2 agonist attenuates ischemic injury in spinal cord neurons.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cardiovascular Surgical Procedures; Cell Survival; Cells, Cultured; Cytokines; Dexmedetomidine; Drug Evaluation, Preclinical; Glucose; Hypoxia; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Spinal Cord; Spinal Cord Injuries | 2015 |
Preclinical efficacy of Dexmedetomidine on spinal cord injury provoked oxidative renal damage.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Caspase 3; Creatinine; Dexmedetomidine; Disease Models, Animal; Interleukin-6; Kidney; Oxidative Stress; Peroxidase; Postoperative Complications; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2015 |
The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats.
Topics: Adrenergic alpha-2 Receptor Agonists; alpha7 Nicotinic Acetylcholine Receptor; Animals; Apoptosis; Dexmedetomidine; Inflammation Mediators; Male; Motor Activity; Myelitis; Neurons; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord Injuries; Toll-Like Receptor 4 | 2017 |
Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study.
Topics: Adrenergic alpha-Agonists; Animals; Antioxidants; Apoptosis; Dexmedetomidine; Disease Models, Animal; Disease Progression; Energy Metabolism; Female; Lipid Peroxidation; Male; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Paraplegia; Rabbits; Spinal Cord; Spinal Cord Injuries; Treatment Failure | 2009 |
Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Dexmedetomidine; Edema; Inflammation; Interleukin-6; Male; Methylprednisolone; Neutrophil Infiltration; Rats; Rats, Wistar; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2009 |
The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats.
Topics: Animals; Aryldialkylphosphatase; Cholesterol, HDL; Dexmedetomidine; Lipid Peroxidation; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord Injuries | 2010 |
Characterization of spinal alpha-adrenergic modulation of nociceptive transmission and hyperalgesia throughout postnatal development in rats.
Topics: Adrenergic alpha-Agonists; Age Factors; Analgesics; Animals; Animals, Newborn; Dexmedetomidine; Dose-Response Relationship, Drug; Electromyography; Heart Rate; Hindlimb; Humans; Infant; Infant, Newborn; Injections, Epidural; Mustard Plant; Nerve Fibers; Pain; Pain Threshold; Plant Oils; Rats; Spinal Cord Injuries | 2007 |